FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023018711> ?p ?o ?g. }

• W2023018711 endingPage "439" @default.
• W2023018711 startingPage "431" @default.
• W2023018711 abstract "Glioblastoma (GB) often has loss of heterozygosity on the chromosomes, 1p, 10p, 10q, 11p, 17p, 19q, 22q, and several others. In the case of chromosome 12q; however, it remains to be seen whether LOH occurs. Apaf-1, the apoptotic protease activating factor-1, located at chromosome 12q22-23, is a major effecter of the p53 mediated apoptosis pathway, and Apaf-1 inactivation due to chromosome 12q22-23 LOH and hypermethylation may be involved in some of the neoplasms in malignancy. However, little is known about the frequency of the 12q22-23 LOH or the state of Apaf-1 in GB. To elucidate their involvement in GB, we analyzed a series of 33 GBs for chromosome 12q22-23 LOH, Apaf-1 mRNA expression, and Apaf-1 protein expression, using microsatellite analysis, reverse transcription (RT) -PCR analysis, and immunohistochemical (IHC) analysis, respectively. We also evaluated if and how the 12q22-23 LOH correlated with the p53 gene mutation and EGFR gene amplification. Chromosome 12q22-23 LOH was detected in 14 (42%) of 33 cases. Among the examined cases with LOH at 12q22-23, a low expression of Apaf-1 mRNA was detected in 9 (69%) of 13 cases, and a low expression of Apaf-1 protein was detected in 12 (86%) of 14 cases. The 12q22-23 LOH was significantly correlated with low expression of mRNA and protein (p<0.05, p<0.001 respectively). The p53 gene mutation and EGFR gene amplification were found in 13 cases (39%) and 8 cases (24%), respectively, and these gene alterations were inversely correlated. However, 12q22-23 LOH had no correlations with the p53 gene mutation or EGFR gene amplification. Six of 9 GBs (67%) with neither p53 gene mutation nor EGFR gene amplification tested positive for 12q22-23 LOH. These GBs are likely to belong to another subset independent from the 2 common genetic subsets in GB (one with p53 gene mutation and without EGFR gene amplification, and the other with EGFR gene amplification and without p53 gene mutation). Twenty-three (70%) out of the 33 GBs with the 12q22-23 LOH also tested positive for Apaf-1 inactivation or p53 gene mutation. This high frequency of alterations in the apoptosis-associated factors prompts a speculation that abrogation of the Apaf-1 and p53 mediated apoptosis pathway may play an important role in the tumorigenesis of GB." @default.
• W2023018711 created "2016-06-24" @default.
• W2023018711 creator A5007639221 @default.
• W2023018711 creator A5018031789 @default.
• W2023018711 creator A5024142978 @default.
• W2023018711 creator A5045058174 @default.
• W2023018711 creator A5045138007 @default.
• W2023018711 creator A5056688287 @default.
• W2023018711 creator A5074654484 @default.
• W2023018711 creator A5081923476 @default.
• W2023018711 date "2006-04-05" @default.
• W2023018711 modified "2023-10-14" @default.
• W2023018711 title "Frequent LOH at Chromosome 12q22-23 and Apaf-1 Inactivation in Glioblastoma" @default.
• W2023018711 cites W115284733 @default.
• W2023018711 cites W1533153036 @default.
• W2023018711 cites W158345141 @default.
• W2023018711 cites W1669929252 @default.
• W2023018711 cites W1969070551 @default.
• W2023018711 cites W1970825472 @default.
• W2023018711 cites W1972122268 @default.
• W2023018711 cites W1976115672 @default.
• W2023018711 cites W1976303784 @default.
• W2023018711 cites W1976570855 @default.
• W2023018711 cites W1981932502 @default.
• W2023018711 cites W1995643652 @default.
• W2023018711 cites W2001854485 @default.
• W2023018711 cites W2012971894 @default.
• W2023018711 cites W2015753497 @default.
• W2023018711 cites W2017068782 @default.
• W2023018711 cites W2018733057 @default.
• W2023018711 cites W2019822740 @default.
• W2023018711 cites W2023368913 @default.
• W2023018711 cites W2024819383 @default.
• W2023018711 cites W2034194437 @default.
• W2023018711 cites W2053535808 @default.
• W2023018711 cites W2056767927 @default.
• W2023018711 cites W2058355285 @default.
• W2023018711 cites W2069294039 @default.
• W2023018711 cites W2074279306 @default.
• W2023018711 cites W2080490195 @default.
• W2023018711 cites W2093833189 @default.
• W2023018711 cites W2094126824 @default.
• W2023018711 cites W2100553819 @default.
• W2023018711 cites W2101631220 @default.
• W2023018711 cites W2112050795 @default.
• W2023018711 cites W2114998237 @default.
• W2023018711 cites W2124049103 @default.
• W2023018711 cites W2131604548 @default.
• W2023018711 cites W2137915568 @default.
• W2023018711 cites W2144701362 @default.
• W2023018711 cites W2146587188 @default.
• W2023018711 cites W2160365879 @default.
• W2023018711 cites W2166708153 @default.
• W2023018711 cites W2332278629 @default.
• W2023018711 cites W2402312039 @default.
• W2023018711 doi "https://doi.org/10.1111/j.1750-3639.2003.tb00474.x" @default.
• W2023018711 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8095738" @default.
• W2023018711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14655749" @default.
• W2023018711 hasPublicationYear "2006" @default.
• W2023018711 type Work @default.
• W2023018711 sameAs 2023018711 @default.
• W2023018711 citedByCount "51" @default.
• W2023018711 countsByYear W20230187112012 @default.
• W2023018711 countsByYear W20230187112013 @default.
• W2023018711 countsByYear W20230187112014 @default.
• W2023018711 countsByYear W20230187112015 @default.
• W2023018711 countsByYear W20230187112016 @default.
• W2023018711 countsByYear W20230187112017 @default.
• W2023018711 countsByYear W20230187112021 @default.
• W2023018711 countsByYear W20230187112023 @default.
• W2023018711 crossrefType "journal-article" @default.
• W2023018711 hasAuthorship W2023018711A5007639221 @default.
• W2023018711 hasAuthorship W2023018711A5018031789 @default.
• W2023018711 hasAuthorship W2023018711A5024142978 @default.
• W2023018711 hasAuthorship W2023018711A5045058174 @default.
• W2023018711 hasAuthorship W2023018711A5045138007 @default.
• W2023018711 hasAuthorship W2023018711A5056688287 @default.
• W2023018711 hasAuthorship W2023018711A5074654484 @default.
• W2023018711 hasAuthorship W2023018711A5081923476 @default.
• W2023018711 hasBestOaLocation W20230187111 @default.
• W2023018711 hasConcept C104317684 @default.
• W2023018711 hasConcept C143589142 @default.
• W2023018711 hasConcept C153911025 @default.
• W2023018711 hasConcept C180754005 @default.
• W2023018711 hasConcept C203014093 @default.
• W2023018711 hasConcept C204232928 @default.
• W2023018711 hasConcept C30481170 @default.
• W2023018711 hasConcept C502942594 @default.
• W2023018711 hasConcept C54355233 @default.
• W2023018711 hasConcept C86803240 @default.
• W2023018711 hasConceptScore W2023018711C104317684 @default.
• W2023018711 hasConceptScore W2023018711C143589142 @default.
• W2023018711 hasConceptScore W2023018711C153911025 @default.
• W2023018711 hasConceptScore W2023018711C180754005 @default.
• W2023018711 hasConceptScore W2023018711C203014093 @default.
• W2023018711 hasConceptScore W2023018711C204232928 @default.
• W2023018711 hasConceptScore W2023018711C30481170 @default.
• W2023018711 hasConceptScore W2023018711C502942594 @default.

• next